September 2025

FastWave lines up principal investigators for pivotal intravascular lithotripsy trial ()
Putting more emphasis on prevention in heart failure care ()
SCAI outlines broken Medicaid reimbursement model for congenital heart disease ()
AI turns mammograms into CVD risk assessments—no outside data required ()
Vulnerable, but treatable: Semaglutide reduces symptoms in high-risk heart failure patients ()
FDA approves treatment of rare genetic disorder in children as young as 1 year old ()
AI delivers helpful heart health advice—but not every time ()
Mavacamten fails to boost outcomes for patients with nonobstructive HCM ()
U.S. considering new tariffs for heart valves, imaging equipment and other medical devices ()
CVD responsible for 1 in 3 deaths around the world ()
How TAVR device type may impact outcomes in patients with excessive cusp calcification ()
A call to action for pediatric cardiologists: CVD prevention begins at childhood ()
Five reasons to switch to Cardiac PET/CT ()
How to bring cardiologists to rural America during a physician shortage ()
TAVR reinterventions: What new data tell us about redo, explant trends over time ()
Semaglutide tops dulaglutide when treating patients with type 2 diabetes and CVD ()
American College of Cardiology shares new expert recommendations on treating tricuspid regurgitation ()
FDA investigating Johnson & Johnson medical devices again after 5 injuries ()
Incoming ASNC president making AI's integration into nuclear cardiology a top priority ()
Safety concern with Johnson & Johnson heart pump controllers leads to Class I recall ()
FDA clears next-generation platform for AI-powered heart assessments ()
Medtech companies team up for new robot capable of treating stroke, aneurysm ()
America’s heart failure epidemic is getting worse ()
Virtual screens could make augmented reality more useful during cardiac ablation ()
SCAI takes on shock-related mortality with door-to-lactate clearance initiative ()
Oral semaglutide linked to significant weight loss as Novo Nordisk awaits FDA approval ()
Stroke risk much higher for TAVR patients with carotid artery stenosis ()
Nuclear imaging groups share new flurpiridaz guideline ()
Top US heart hospital launches new AI research lab ()
Abbott warns EP labs the tip can detach from its TactiFlex ablation catheters ()
ACC: Global health workforce is in need of investment to combat noncommunicable diseases ()
St. Luke’s cuts PAD amputation rate in half with heart team-led wound transition program ()
World’s most populous country gains access to Medtronic’s newest TAVR valve ()
New registry helps hospitals expand outpatient services for heart patients ()
FDA highlights risks of evaluating blood pressure with unauthorized medical devices ()
FDA approves nasal spray for edema associated with congestive heart failure ()
Cardiologists lead charge for medical device approvals in Europe to be more rigorous ()
Medline recalls surgical kits due to safety concern with Medtronic catheters ()
Shockwave Medical launches new IVL catheter for challenging lesions in Europe ()
Multimodality imagers play a critical role in modern heart teams ()
FDA clears Apple Watch algorithm for detecting hypertension ()
Update: FDA confirms recalls for defibrillation leads after nearly 400 injuries ()
Dexcom issues new recall for CGM apps due to safety risk—users urged to update immediately ()
Cardiologist sues hospital after he was allegedly let go for sharing safety concerns ()
Why all heart patients should be vaccinated against the flu, COVID-19, RSV ()
Heart surgeons see more potential in AI than colleagues from other fields ()
FDA clears AI-powered cardiac imaging platform ()
New Apple Watch Ultra 3 makes early hypertension detection a priority ()
Key trends in nuclear cardiology take center stage at ASNC 2025 ()
Open-source AI model delivers accurate echocardiography assessments ()
ASNC calls on members to fight 57% Medicare cut for cardiac amyloid imaging ()
Cardiologist Carlos Collet takes new leadership role with CRF ()
Boston Scientific to purchase Elutia’s drug-eluting envelope business for $88M ()
Plant-based diets linked to lower risks of death, heart disease, stroke and diabetes ()
TAVR still a safe option for patients with nickel allergies ()
First study of its kind to focus on new therapy for hypoplastic left heart syndrome ()
Why patient selection is so important when performing M-TEER ()
Exploring the link between left ventricular diastolic function and AFib ()
FDA clears single-use, fully disposable endovascular robotic system ()
DanGer Shock update: Impella CP heart pump linked to long-term survival benefit ()
Q&A: Cardiologist explores CMS proposal to cover cardiac ablations performed in ambulatory surgical centers ()
FDA clears GE Revolution Vibe CT scanner aimed at rapidly growing CCTA market ()
FDA clears Kardium Globe pulsed field ablation system ()
Advances in electrosurgical techniques have helped thousands of transcatheter valve patients ()
Update: FDA announces new Class I recalls due to safety issue with Medtronic catheters ()
Philips launches smart telemetry platform for cardiac monitoring ()
3D echo guidance seeing increasing use in congenital heart surgery ()
First commercial robotically navigated, high-density EP mapping procedures performed in US ()
How to address CCTA staffing shortages ()
FDA clears first large-bore, vacuum-assisted pulmonary embolism thrombectomy system ()
ESC Congress broke new record with over 33,000 attendees ()
Seeing is believing: New cath lab technology takes coronary stent visualization to the next level ()
Medtronic’s RDN system approved in Japan ()
Drug-coated balloons make little impact on PAD outcomes ()
Johnson & Johnson’s PFA platform is both safe and effective, real-world data confirm ()
Real-world data link semaglutide, tirzepatide to improved heart failure outcomes ()
Beta blockers ‘have no effect’ on heart attack patients ()